Breath activated inhaler usage and impact on rescue medication usage in patients with an asthma diagnosis: a prescribing claims study of 2823 patients using a CFC - pMDI and a breath-actuated device

D. Price, G. Mitchell (Aberdeen, Bicester, United Kingdom)

Source: Annual Congress 2001 - Inhalation devices and technique
Session: Inhalation devices and technique
Session type: Thematic Poster Session
Number: 544
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Price, G. Mitchell (Aberdeen, Bicester, United Kingdom). Breath activated inhaler usage and impact on rescue medication usage in patients with an asthma diagnosis: a prescribing claims study of 2823 patients using a CFC - pMDI and a breath-actuated device. Eur Respir J 2001; 16: Suppl. 31, 544

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012


Accuracy of inhaler and nebulizer prescribing in hospitalized patients
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011

How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005

Asthma control with a breath-actuated pressurised metered dose inhaler (BAI) and prevalence of oral candidiasis: a prescribing claims study of 1701 patients prescribed a traditional pressurised metered dose inhaler (MDI) plus spacer or a BAI
Source: Eur Respir J 2002; 20: Suppl. 38, 78s
Year: 2002

Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
Source: Eur Respir J 2002; 19: 246-251
Year: 2002



COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Comparison of HFA salmeterol-fluticasone (SFC) combination when given through breath actuated inhaler (BAI) and pressurised meter dose inhaler (pMDI) in patients with moderate-to-severe asthma
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016


The use of pressurized metered-dose inhalers mith spacer in the treatment of asthmatic crises: impacts on treatment costs
Source: Eur Respir J 2006; 28: Suppl. 50, 710s
Year: 2006

Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Critical handling errors with dry-powder, metered dose and soft-mist inhaler devices in an observational COPD study
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019


How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs)
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Training patients on how to use metered dose inhaler (MDI) by using the 2Tone will improve asthma quality of life (AQOL)
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


Switch to Budesonide/Formoterol Easyhaler Inhalation from other inhalers in asthma patients; A real-life study
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


Preferences for current inhaler devices in patients with asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018


The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018



Patient inhaler satisfaction with Spiromax Budesonide/Formoterol versus Diskus Fluticasone/Salmeterol in COPD
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019

Feedback during treatment results in increased adherence when using a pressurized metered dose inhaler with valved holding chamber in paediatric patients with asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008